Cargando…
Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease
Beta (β)-blockers are under-prescribed in patients with heart failure (HF) and concurrent chronic obstructive pulmonary disease (COPD) due to concerns about adverse pulmonary effects and a poor understanding of the effects of these drugs. We aimed to evaluate the survival effects of β-blockers in pa...
Autores principales: | Su, Vincent Yi-Fong, Chang, Yu-Sheng, Hu, Yu-Wen, Hung, Man-Hsin, Ou, Shuo-Ming, Lee, Fa-Yauh, Chou, Kun-Ta, Yang, Kuang-Yao, Perng, Diahn-Warng, Chen, Tzeng-Ji, Liu, Chia-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748871/ https://www.ncbi.nlm.nih.gov/pubmed/26844454 http://dx.doi.org/10.1097/MD.0000000000002427 |
Ejemplares similares
-
Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease: Erratum
Publicado: (2016) -
Differential Effects of the Betablockers Carvedilol, Metoprolol and Bisoprolol on Cardiac K(v)4.3 (I(to)) Channel Isoforms
por: Rahm, Ann-Kathrin, et al.
Publicado: (2023) -
Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10‐Year Cohort
por: Tang, Chao‐Hsiun, et al.
Publicado: (2016) -
Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol
por: Barold, S. Serge, et al.
Publicado: (2018) -
Carvedilol versus Metoprolol in Patients with Ventricular Tachyarrhythmias
por: Schupp, Tobias, et al.
Publicado: (2022)